J&J's cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
Enhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread throughout the body, marking a breakthrough in cancer treatment. It s the first antibody drug conjugate with such wide clearance, offering new hope for patients with limited treatment options. AstraZeneca anticipates further growth opportunities.
5 things to know before the stock market opens Tuesday : Rashtra News #stock #market #opens #Tuesday Here are the most important news, trends and analysis that investors need to start their trading day:1. Futures steady with earnings, rising bond yields in focusTraders work on the floor of the New York Stock Exchange during morning